Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,518.9
-11.4 (-0.45%)

 

  • STI Straits Times Index
    2,518.9
    -11.4 (-0.45%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,449.0
    12.2 (0.85%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    23,301.4
    -83.3 (-0.36%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    2,836.8
    -9.7 (-0.34%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    21,419.2
    148.1 (0.70%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    4,641.6
    14.8 (0.32%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,221.7M
  • Value: 1,172.2M
  • Rise: 157
  • Fall: 140
  • Unch: 511

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Reenova Investment^0.003+0.001
Medtecs Intl0.235+0.045
Rex Intl0.144-
UG Healthcare0.455+0.085
Clearbridge0.205+0.021
Singapore-eDev0.056+0.003
ComfortDelGro1.530-
Genting Sing0.780+0.020
Singtel2.620-0.040
Golden Agri-Res0.150+0.003

World Indices

World Indices
Name Last Change
Nasdaq 9,340.2 +15.6
HSI 23,301.4 -83.3
HSCEI 9,567.4 -27.8
Jakarta 4,641.6 +14.8
Nikkei 225 21,419.2 +148.1
SSE Comp 2,836.8 -9.7
Shanghai A 2,973.3 -10.2
Shanghai B 207.0 -1.1
KOSPI 2,031.2 +1.4

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

NANOVIRICIDES INC NANOVIRICIDES
Updated on 26 May 2020 (End of trading day)
Last (USD): 7.510 Change: -0.060 High: 7.670 Remarks: -
Change (%): -0.79 Low: 7.250
Open 7.500 Yesterday's Close 7.569999999999999
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 670,042 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -0.13357 Trailing EPS (USD) e -0.12431 NAV (USD) b 0.1224
PE a - Trailing PE f - Price / NAV b 61.3562
Dividend (USD) d - Cash In Hand (USD) g 0.0112 Issued & Paid-up Shares c 9,092,190
Dividend Yield (%) d - Price / Cash In Hand g 670.536 Treasury Shares h -
Beta - 75 Daysi - R-Squared - 75 Days(%)i - Market Cap (M) 473.671
Beta - 500 Daysi - R-Squared - 500 Days (%)i - Enterprise Value (M) 474.025
Piotroski F Score 1 Exchange Code NNVC Par Value ( $ ) n.a.
52 Weeks Volatility (%) 193.98 Free Float (%) 69.3
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 25 May 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 29 Jul 2015.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference NANOVIRICIDES INC NYSE American 473.671 - - 61.3562 -
Industry Biotechnology NYSE American 117.514 - - 3.5045 -
Local Peer CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL NYSE American 310.362 - - 334.9206 -
Local Peer PFENEX INC NYSE American 161.880 152.991 - 1.9463 -
Local Peer IBIO INC NYSE American 152.223 - - 38.4075 -
Local Peer CEL-SCI CORP NYSE American 126.783 - - 10.3846 -
Local Peer LINEAGE CELL THERAPEUTICS INC NYSE American 154.316 - - 1.4491 -
Local Peer 22ND CENTURY GROUP INC NYSE American 87.459 - - 1.5000 -
Local Peer MATINAS BIOPHARMA HOLDINGS INC NYSE American 83.695 - - 1.1365 -
Local Peer PALATIN TECHNOLOGIES INC NYSE American 73.238 2.047 1.974 0.8449 -
Local Peer AIM IMMUNOTECH INC NYSE American 70.048 - - 2.0398 -
Local Peer ARMATA PHARMACEUTICALS INC NYSE American 65.816 - - 1.9657 -
Local Peer SYNTHETIC BIOLOGICS INC NYSE American 43.450 - - -8.3243 -
Local Peer ORAGENICS INC NYSE American 29.387 - - 5.1237 -
Other Local Peers INDIA GLOBALIZATION CAPITAL INC (NYSE American), ACTINIUM PHARMACEUTICALS INC (NYSE American), NOVABAY PHARMACEUTICALS INC (NYSE American)
Global Peer AMGEN INC NASDAQ 130,826.133 16.683 17.046 13.7929 2.622
Global Peer GILEAD SCIENCES INC NASDAQ 91,767.720 17.038 18.494 4.1586 3.477
Global Peer CSL ASX 139,679.094 52.062 48.219 16.1508 0.862
Global Peer AMGEN-T HKEx 588,247.000 9.574 9.804 8.0015 4.569
Global Peer VERTEX PHARMACEUTICAL NASDAQ 69,097.321 58.716 45.732 10.6934 -
Global Peer REGENERON PHARMACEUTICALS INC NASDAQ 61,348.103 28.995 26.915 5.0563 -
Global Peer ILLUMINA INC NASDAQ 52,098.270 51.994 55.306 11.2402 -
Global Peer BIOGEN INC NASDAQ 48,282.138 8.199 8.213 3.8481 -
Global Peer SEATTLE GENETICS INC NASDAQ 26,264.766 - - 14.8756 -
Global Peer AGILENT TECHNOLOGIES INC NYSE 26,670.241 24.902 39.049 5.5936 0.760
Other Global Peers MODERNA INC (NASDAQ), ALEXION PHARMACEUTICAL INC (NASDAQ), INCYTE CORPORATION (NASDAQ), WUXI BIO (HKEx), SINO BIOPHARM (HKEx), BIOMARIN PHARMACEUTICAL (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), BEIGENE (HKEx), EXACT SCIENCES CORP (NASDAQ), BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), BIONTECH SE SPON ADS EACH REP 1 ORD SHS (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), BIO-TECHNE CORP (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), IMMUNOMEDICS INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), EXELIXIS INC (NASDAQ), 10X GENOMICS INC (NASDAQ), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), ACCELERON PHARMA (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), EMERGENT BIOSOLUTIONS INC (NYSE), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), Lonza (SGX), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), GENSCRIPT BIO (HKEx), VIR BIOTECHNOLOGY INC (NASDAQ), MOMENTA PHARMACEUTICALS INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), FIBROGEN INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), VIELA BIO INC (NASDAQ), 3SBIO (HKEx), ARENA PHARMACEUTICALS INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), UNIQURE N.V. (NASDAQ), TG THERAPEUTICS INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), ALKERMES PLC (NASDAQ), NOVAVAX INC (NASDAQ), ALECTOR INC (NASDAQ), INSMED INC (NASDAQ), BENITEC BIOPHARMA INC (NASDAQ), ALPHAMAB-B (HKEx), EPIZYME INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), XENCOR INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), EIDOS THERAPEUTICS INC (NASDAQ), ARVINAS INC (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), EDITAS MEDICINE INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), ARCUS BIOSCIENCES INC (NYSE), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), CORTEXYME INC (NASDAQ), REGENXBIO INC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), VIVA BIOTECH (HKEx), KARYOPHARM THERAPEUTICS INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), BLACK DIAMOND THERAPEUTICS INC (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), ZENTALIS PHARMACEUTICALS INC (NASDAQ), MESOBLAST LTD (ASX), NGM BIOPHARMACEUTICALS INC (NASDAQ), BEAM THERAPEUTICS INC (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), CYTOKINETICS INC (NASDAQ), TRANSLATE BIO INC (NASDAQ), VERACYTE INC (NASDAQ), HAOHAI BIOTEC (HKEx), MACROGENICS INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), POLYNOVO LIMITED (ASX), NANOSTRING TECHNOLOGIES INC (NASDAQ), MYOVANT SCIENCES LTD (NYSE), COMPUGEN (NASDAQ), PASSAGE BIO INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), AIMMUNE THERAPEUTICS INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), FRONTAGE (HKEx), INTELLIA THERAPEUTICS INC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), KINTOR PHARMA-B (HKEx), KURA ONCOLOGY INC (NASDAQ), NEXTCURE INC (NASDAQ), IMMUNOGEN INC (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), CUE BIOPHARMA INC (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), OMEROS CORP (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC ADS EACH REPR 6 SHS (SPONS) (NASDAQ), KADMON HLDGS INC (NYSE), MOLECULAR TEMPLATES INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), RETROPHIN INC (NASDAQ), ASCENTAGE-B (HKEx), HOMOLOGY MEDICINES INC (NASDAQ), ARDELYX INC (NASDAQ), AVITA MEDICAL LTD (ASX), AVITA MEDICAL LTD SPON ADS EACH REP 20 ORD SHS (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), AVROBIO INC (NASDAQ), MORPHIC HOLDING INC (NASDAQ), STEMLINE THERAPEUTICS INC (NASDAQ), PREVAIL THERAPEUTICS INC (NASDAQ), BELLUS HEALTH INC (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), ATHERSYS INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), NEUROINSIGHTS NEUROTECH (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), VBI VACCINES INC CDA (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), NANTKWEST INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), ANAPTYSBIO INC (NASDAQ), UROGEN PHARMA LTD (NASDAQ), SINOMAB BIO-B (HKEx), TRILLIUM THERAPEUTICS INC (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), NEOLEUKIN THERAPEUTICS INC (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), PROTHENA CORP PLC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), MERUS B V (NASDAQ), PRECIGEN INC (NASDAQ), RAPT THERAPEUTICS INC (NASDAQ), ASCLETIS-B (HKEx), SYROS PHARMACEUTICALS INC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), AGENUS INC (NASDAQ), XBIOTECH INC (NASDAQ), SERES THERAPEUTICS (NASDAQ), PERSONALIS INC (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), PDL BIOPHARMA INC (NASDAQ), KAMADA (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), GERON CORP (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), ESSEX BIO-TECH (HKEx), SELECTA BIOSCIENCES INC (NASDAQ), PROGENICS PHARMACEUTICALS INC (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), MANNKIND CORPORATION (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), VERASTEM INC (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), AVID BIOSERVICES INC (NASDAQ), LEE'S PHARM (HKEx), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), CHIASMA INC (NASDAQ), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), SUMMIT THERAPEUTICS PLC ADS EACH REPR 5 ORD (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), DPHARMA (Bursa), CYMABAY THERAPEUTICS INC (NASDAQ), VERMILLION INC (NASDAQ), ADURO BIOTECH INC (NASDAQ), BBI LIFE SCI (HKEx), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), MEDICINOVA INC (NASDAQ), TELIX PHARMACEUTIC (ASX), XOMA CORP (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), AFFIMED N V (NASDAQ), NEUROBO PHARMACEUTICALS INC (NASDAQ), AXCELLA HEALTH INC (NASDAQ), VAXART INC (NASDAQ), INFLARX N V (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), IMV INC (NASDAQ), IVERIC BIO INC (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), CHIMERIX INC (NASDAQ), ARAVIVE INC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), LIMINAL BIOSCIENCES INC (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), NEXT SCIENCE LTD (ASX), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), ORGENESIS INC (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), ENZO BIOCHEM INC (NYSE), TREVENA INC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), AXOVANT GENE THERAPIES LTD (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), GLYCOMIMETICS INC (NASDAQ), CABALETTA BIO INC (NASDAQ), WINDTREE THERAPEUTICS INC (NASDAQ), SAVARA INC (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), UNI-BIO GROUP (HKEx), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), CELYAD ADS EACH REPR 1 ORD (NASDAQ), LUMOS PHARMA INC (NASDAQ), NEUREN PHARMACEUTICALS LTD (ASX), COHBAR INC (NASDAQ), RECRO PHARMA INC (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), IMUGENE LIMITED (ASX), CAPRICOR THERAPEUTICS INC (NASDAQ), SESEN BIO INC (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), PROTEOSTASIS THERAPEUTICS INC (NASDAQ), CONTRAFECT CORP (NASDAQ), MONOPAR THERAPEUTICS INC (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), RESTORBIO INC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), OTONOMY INC (NASDAQ), SYNLOGIC INC (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), INMUNE BIO INC (NASDAQ), VACCINEX INC (NASDAQ), ANPAC BIO MEDICAL SCIENCE CO LTD SPON ADS EACH REPR 1 ORD SHS CLASS A (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), SOLIGENIX INC (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), 9 METERS BIOPHARMA INC (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), EQUILLIUM INC (NASDAQ), INVEX THERAPEUTICS LTD NPV (ASX), MICROBOT MEDICAL INC (NASDAQ), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), IMMUTEP LTD (ASX), CYNATA THERAPEUTICS LTD (ASX), OPIANT PHARMACEUTICALS INC (NASDAQ), SUNESIS PHARMACEUTICALS INC (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), BIOTRON (ASX), ADVAXIS INC (NASDAQ), ZAFGEN INC (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 14 ORD SHS (NASDAQ), CT ENTERPRISE (HKEx), SONNET BIOTHERAPEUTICS HLDGS INC (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), ATYR PHARMA INC (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), TOCAGEN INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), MIRAGEN THERAPEUTICS INC (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), BIONANO GENOMICS INC (NASDAQ), MEMPHASYS LTD (ASX), BIOSINO BIO-TEC (HKEx), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), CURIS INC (NASDAQ), EVOGENE LTD (NASDAQ), BIOCARDIA INC (NASDAQ), HOLISTA COLLTECH LIMITED (ASX), CORREVIO PHARMA CORP (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), CYCLACEL PHARMACEUTICALS INC (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), KAZIA THERAPEUTICS LIMITED (ASX), ANTEOTECH LIMITED (ASX), AETERNA ZENTARIS INC (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), AIKIDO PHARMA INC (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), CCP TECHNOLOGIES LTD (ASX), GENETIC TECHNOLOGIES (ASX), VISTAGEN THERAPEUTICS INC (NASDAQ), OCUGEN INC (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), Suntar Eco-City^ (SGX), BIONOMICS LTD (ASX), CONATUS PHARMACEUTICALS INC (NASDAQ), REGENT PACIFIC (HKEx), UNUM THERAPEUTICS INC (NASDAQ), SIENNA CANCER DIAGNOSTICS LTD (ASX), ACHIEVE LIFE SCIENCE INC (NASDAQ), REGENEUS LTD (ASX), ALTERITY THERAPEUTICS LIMITED (ASX), CELLECTAR BIOSCIENCES INC (NASDAQ), ACTINOGEN MEDICAL LTD (ASX), RHINOMED LIMITED (ASX), PRESCIENT THERAPEUTICS LIMITED (ASX), ENDRA LIFE SCIENCES INC (NASDAQ), SENECA BIOPHARMA INC (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), PRECIPIO INC (NASDAQ), PATRYS LIMITED (ASX), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), REXAHN PHARMACEUTICALS INC (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), ADALTA LTD (ASX), AVECHO BIOTECHNOLOGY LTD (ASX), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), CONTANGO ASSET MANAGEMENT LIMITED (ASX), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), HAO WEN HLDGS (HKEx), MIDATECH PHARMA PLC SPON ADS EACH REP 5 ORD SHS(R/S) (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), AMPLIA THERAPEUTICS LTD (ASX), ANATARA LIFESCIENCES LTD (ASX), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), SENESTECH INC (NASDAQ), AUSTRALIAN PRIMARY HEMP LTD (ASX), AURIS MEDICAL HOLDING LTD (NASDAQ), LIVING CELL TECHNOLOGIES (ASX), LEAF RESOURCES LTD (ASX), CRYOSITE (ASX), THERAPIX BIOSCIENCES LTD SPON ADR EACH REP 40 ORD (POST SPLIT) (NASDAQ), NANOLLOSE LTD (ASX), FACTOR THERAPEUTICS LIMITED (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --1.580
-17.38 %
10 Days --3.030
-28.75 %
20 Days -+1.700
+29.26 %
Medium Term Return 3 Months --1.660
-18.10 %
6 Months -+4.270
+131.79 %
1 Year -+2.510
+50.20 %
Long Term Return 2 Years --3.690
-32.95 %
3 Years --17.090
-69.47 %
5 Years --29.090
-79.48 %
Annualised Return Annualised --
-27.15 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 1.271 - 19.200 Change From 1 Year Low +6.239 % Change From 1 Year Low (%) +490.73
Change From 1 Year High -11.690 % Change From 1 Year High (%) -60.89
2 Years Range 1.271 - 19.200 Change From 2 Years Low +6.239 % Change From 2 Years Low (%) +490.73
Change From 2 Years High -11.690 % Change From 2 Years High (%) -60.89
5 Years Range 1.271 - 68.800 Change From 5 Years Low +6.239 % Change From 5 Years Low (%) +490.73
Change From 5 Years High -61.290 % Change From 5 Years High (%) -89.08
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

NanoViricides, Inc. is a development stage company, which engages in the development of nanomedicine drugs against viruses. It focuses on anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs. The company was founded by Anil R. Diwan on April 1, 2005 and is headquartered in Shelton, CT.

Historical Price Data

Date Open High Low Close Volume VWAP
26 May 2020 7.500 7.670 7.250 7.510 670,042 -
22 May 2020 7.600 7.690 7.300 7.570 696,229 -
21 May 2020 8.000 8.300 7.530 7.660 1,777,275 -
20 May 2020 8.690 9.580 8.660 9.090 1,274,674 -
19 May 2020 9.730 10.060 9.400 9.650 715,393 -
18 May 2020 9.530 10.600 8.550 10.140 1,464,925 -
15 May 2020 10.640 11.280 9.510 9.630 1,367,687 -
14 May 2020 11.050 12.200 10.543 11.560 3,031,953 -
13 May 2020 8.750 10.580 8.110 10.540 2,393,423 -
12 May 2020 9.650 10.600 8.410 9.120 12,407,300 -
11 May 2020 6.240 7.350 6.240 7.110 747,357 -
08 May 2020 6.090 6.360 6.030 6.300 169,613 -
07 May 2020 6.290 6.290 6.110 6.140 119,677 -
06 May 2020 6.150 6.270 6.000 6.160 184,319 -
05 May 2020 6.600 6.630 6.060 6.130 458,719 -
04 May 2020 6.200 6.700 6.000 6.630 1,108,763 -
01 May 2020 5.680 5.960 5.600 5.780 143,743 -
30 Apr 2020 5.780 6.090 5.600 6.000 250,093 -
29 Apr 2020 6.250 6.290 5.780 5.810 419,362 -
28 Apr 2020 6.220 6.400 6.050 6.200 357,871 -
27 Apr 2020 6.160 6.450 6.050 6.200 453,539 -
24 Apr 2020 6.190 6.750 6.140 6.450 497,712 -
Summary
Current 2 Weeks
(12 May 2020 to 26 May 2020)
9.650 12.200 7.250 7.510 25,798,901 -
Previous 2 Weeks
(28 Apr 2020 to 11 May 2020)
6.220 12.200 6.050 7.110 3,959,517 -
4 Weeks from
(30 Mar 2020 to 27 Apr 2020)
5.700 12.200 5.450 6.200 14,170,249 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.